Immune checkpoint signaling and cancer immunotherapy
Abstract Immune checkpoint blockade therapy has become a major weapon in fighting cancer. Antibody drugs, such as anti-PD-1 and anti-PD-L1, demonstrate obvious advantages such as broad applicability across cancer types and durable clinical response when treatment is effective. However, the overall r...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Revisão |
| Language: | English |
| Published: |
2020
|
| Online Access: | https://doi.org/10.1038/s41422-020-0343-4 https://www.nature.com/articles/s41422-020-0343-4.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|